See also this year's filing and all EDGAR filings for this company.
PDF Report 0001178879_2013_Amicus_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 0.8879913506834505, 'aggregate_val': 122238000, 'exp_sum': 64745000, 'exp_to_value': {'remainder_Revenues': 64745000}} |
Graph
Absolute values for 0001178879, Amicus Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 104,617,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,029,000 |
| 3 | remainder_Assets | 442,000 |
| 4 | LiabilitiesCurrent | 9,243,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,364,000 |
| 9 | ResearchAndDevelopmentExpense | 50,273,000 |
| 10 | remainder_Expenses | -2,104,000 |
| 11 | remainder_Revenues | 18,411,000 |
| 12 | remainder_NetIncome | 337,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 110,088,000 |
| 1 | Liabilities | 9,243,000 |
| 2 | Expenses | 67,533,000 |
| 3 | Revenues | 18,411,000 |
| 4 | StockholdersEquity | 100,845,000 |
| 5 | NetIncome | -48,785,000 |
| 6 | ComprehensiveNetIncome | -48,785,000 |
| 7 | BaseVar | 102,806,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.87 |
| 9 | EconomicCapitalRatio | 3.60 |